ClickDiagnostics Raises $70 Million
ClickDiagnostics’s technology enables molecular biology and polymerase chain reaction (PCR) testing to be performed outside of designated labs
Hagar Ravet | 13:27, 05.04.20
San Jose, California-based ClickDiagnostics Inc. has raised a $70 million funding round, the company announced Sunday. The round was led by Cedars-Sinai Medical Center in Los Angeles, private investor John Doerr, and Israel-based firm Pitango Venture Capital.
Founded in 2012 by Israeli entrepreneur Adam de la Zerda, ClickDiagnostics develops technology designed to democratize advanced biological testing. Click’s technology enables molecular biology and polymerase chain reaction (PCR) testing to be performed outside of designated professional labs, for example, in medical clinics. Eventually, the company aims to enable advanced testing at home. The company has raised $201 million to date, according to Pitchbook data.
